What is Digital Artefacts?
Digital Artefacts operates as a specialized provider of advanced technology solutions designed to transform the clinical research ecosystem. By focusing on the capture of complex cognitive, behavioral, and physiological data, the company enables sponsors and contract research organizations to execute decentralized clinical trials with unprecedented precision. Their product suite, which includes eSource and sophisticated data capture tools, addresses critical needs in therapeutic areas such as oncology, immunology, and diabetes. Through its integration into the broader Clinical ink portfolio, Digital Artefacts enhances the ability to synthesize disparate data streams into actionable insights, thereby reducing the burden on patients and improving the overall quality of clinical evidence.
How much funding has Digital Artefacts raised?
Digital Artefacts has raised a total of $433K across 2 funding rounds:
Debt
$150K
Debt
$283K
Debt (2020): $150K with participation from PPP
Debt (2021): $283K led by PPP
Key Investors in Digital Artefacts
PPP
Public-Private Partnership
What's next for Digital Artefacts?
With the successful completion of this late-stage financing, Digital Artefacts is poised to scale its operational capabilities and expand its footprint in the digital health market. The strategic focus will likely center on deepening the integration of its data capture technologies within the decentralized clinical trial framework. By prioritizing the development of scalable, patient-centric platforms, the company aims to solidify its market position as a leader in health technology innovation. Future growth will be driven by the continued adoption of its eSource solutions, as the industry increasingly demands high-fidelity data that can be captured remotely and securely. This capital deployment will be instrumental in maintaining a competitive edge while addressing the evolving regulatory and clinical requirements of global research sponsors.
See full Digital Artefacts company page
